DNA damage-inducible transcript 3
Ensembl | |||||||||
---|---|---|---|---|---|---|---|---|---|
UniProt | |||||||||
RefSeq (mRNA) |
| ||||||||
RefSeq (protein) |
| ||||||||
Location (UCSC) | Chr 12: 57.52 – 57.52 Mb | Chr 10: 127.13 – 127.13 Mb | |||||||
PubMed search | [3] | [4] |
View/Edit Human | View/Edit Mouse |
DNA damage-inducible transcript 3, also known as C/EBP homologous protein (CHOP), is a pro-
Structure
C/EBP proteins are known to have a conserved
Regulation and function
Due to a variety of upstream and downstream regulatory interactions, CHOP plays an important role in
Under normal physiological conditions, CHOP is ubiquitously present at very low levels.
Upstream regulatory pathways
During
Integrated stress response, and thus CHOP expression, can be induced by
- amino acid starvation through general control non-derepressible-2 (GCN2)[13]
- viral infection through the vertebrate-specific kinases - double-stranded RNA-activated protein kinase (PKR)[14]
- iron deficiency through HRI)[15]
- stress from the accumulation of unfolded or misfolded proteins in the ER activates the integrated stress response through protein kinase RNA-like endoplasmic reticulum kinase (PERK).[16]
Under ER stress, activated transmembrane protein ATF6 translocates to the nucleus and interacts with ATF/cAMP response elements and ER stress-response elements,[17] binding the promoters and inducing transcription of several genes involved in unfolded protein response (including CHOP, XBP1 and others).[18][19] Thus, ATF6 activates the transcription of both CHOP and XBP-1, while XBP-1 can also upregulate the expression of CHOP.[20]
ER stress also stimulates transmembrane protein IRE1α activity.[21] Upon activation, IRE1α splices the XBP-1 mRNA introns to produce a mature and active XBP-1 protein,[22] that upregulates CHOP expression[23][24][25] IRE1α also stimulates the activation of the apoptotic-signaling kinase-1 (ASK1), which then activates the downstream kinases, Jun-N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK),[26] which participate in apoptosis induction along with CHOP.[27] The P38 MAP kinase family phosphorylates Ser78 and Ser81 of CHOP, which induces cell apoptosis.[28] Moreover, research studies found that the JNK inhibitors can suppress CHOP upregulation, indicating that JNK activation is also involved in the modulation of CHOP levels.[29]
Downstream pathways
Apoptosis induction via Mitochondria-Dependent Pathway
As a transcription factor, CHOP can regulate the expression of many anti-apoptotic and
Under ER stress, CHOP can function as either a
TRB3 pseudokinase is upregulated by the ER stress-inducible transcriptional factor, ATF4-CHOP.[38] CHOP interacts with TRB3, which contributes to the induction of apoptosis.[39][40][41] The expression of TRB3 has a pro-apoptotic capacity.[42][43] Therefore, CHOP also regulates apoptosis by upregulating the expression of the TRB3 gene.
Apoptosis induction via Death-Receptor Pathway
The PERK-ATF4-CHOP pathway can induce
Under prolonged ER stress conditions, activation of the PERK-CHOP pathway will permit DR5 protein levels to rise, which accelerates the formation of the death-inducing signaling complex (DISC) and activates caspase-8,[46] leading to apoptosis[47]
Apoptosis induction through other downstream pathways
In addition, CHOP also mediates apoptosis through increasing the expression of the ERO1α (ER reductase)[10] gene, which catalyzes the production of H2O2 in the ER. The highly oxidized state of the ER results in H2O2 leakage into the cytoplasm, inducing the production of reactive oxygen species (ROS) and a series of apoptotic and inflammatory reactions.[10][48][49][50]
The
Under most conditions, CHOP can directly bind to the
In general, the downstream targets of CHOP regulate the activation of apoptotic pathways, however, the molecular interaction mechanisms behind those processes remain to be discovered.
Interactions
DNA damage-inducible transcript 3 has been shown to
Clinical significance
Role in fatty liver and hyperinsulinemia
Chop gene deletion has been demonstrated protective against diet induced metabolic syndromes in mice.[60][61] Mice with germline Chop gene knockout have better glycemic control despite unchanged obesity. A plausible explanation for the observed dissociation between obesity and insulin resistance is that CHOP promotes insulin hypersecretion from pancreatic β cells.[62]
Furthermore, Chop depletion by a GLP1-ASO delievery system[63] was shown to have therapeutic effects of insulin reduction and fatty liver correction,[64] in preclinical mouse models.[62]
Role in microbial infection
CHOP-induced apoptosis pathways had been identified in cells infected by
- Porcine circovirus type 2 (PERK-eIF2α-ATF4 -CHOP-BCL2 pathway)[65]
- HIV (XBP-1-CHOP-Caspase 3/9 pathway)[66][67]
- Infectious bronchitis virus (PERK-eIF2α-ATF4/PKR-eIF2α-ATF4 pathway)[68]
- M. tuberculosis (PERK-eIF2α-CHOP pathway)[69][70]
- Helicobacter pylori (PERK-CHOP or PKR-eIF2α-ATF4 pathway)[71]
- Escherichia coli (CHOP-DR5-Caspase 3/8 pathway)[72]
- Shigella dysenteriae (p38-CHOP-DR5 pathway)[73]
Since CHOP has an important role of apoptosis induction during infection, it is an important target for further research that will help deepen the current understanding of pathogenesis and potentially provide an opportunity for invention of new therapeutic approaches. For example, small molecule inhibitors of CHOP expression may act as therapeutic options to prevent ER stress and microbial infections. Research had shown that small molecule inhibitors of PERK-eIF2α pathway limit PCV2 virus replication.[65]
Role in other diseases
The regulation of CHOP expression plays an important role in metabolic diseases and in some cancers through its function in mediating apoptosis. The regulation of CHOP expression could be a potential approach to affecting cancer cells through the induction of apoptosis.[51][29][44][74] In the intestinal epithelium, CHOP has been demonstrated to be downregulated under inflammatory conditions (in inflammatory bowel diseases and experimental models of colitis). In this context, CHOP seems to rather regulate the cell cycle than apoptotic processes.[75]
Mutations or fusions of CHOP (e.g. with
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000175197 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000025408 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- PMID 1990262.
- ^ a b c "Entrez Gene: DDIT3 DNA-damage-inducible transcript 3".
- PMID 8657121.
- ^ PMID 28743963.
- PMID 1547942.
- ^ PMID 19752026.
- PMID 14685163.
- S2CID 25715028.
- PMID 27135434.
- PMID 26381255.
- PMID 29293089.
- PMID 27211800.
- PMID 23850759.
- PMID 19723703.
- S2CID 51711178.
- PMID 10958673.
- PMID 19665977.
- S2CID 9460062.
- S2CID 33644823.
- PMID 29230213.
- S2CID 7652866.
- S2CID 20439571.
- S2CID 15705605.
- PMID 21691066.
- ^ S2CID 3570039.
- PMID 21068199.
- S2CID 17713296.
- PMID 22761832.
- PMID 21159964.
- PMID 8657121.
- PMID 26587781.
- PMID 20651282.
- PMID 27798841.
- PMID 20660016.
- S2CID 13709561.
- S2CID 19428363.
- PMID 15775988.
- S2CID 43360696.
- PMID 29391905.
- ^ PMID 25770212.
- PMID 26983464.
- PMID 24994655.
- PMID 17562483.
- PMID 15601821.
- ^ PMID 8637704.
- PMID 21135141.
- ^ PMID 25792543.
- PMID 26729625.
- PMID 23448667.
- PMID 8622660.
- ^ PMID 10523647.
- S2CID 43792576.
- PMID 8662954.
- PMID 12876286.
- PMID 10713066.
- PMID 18776938.
- S2CID 12850216.
- ^ PMID 34321322.
- AstraZeneca AB
- PMID 34163039.
- ^ PMID 26907328.
- PMID 25409632.
- PMID 26740125.
- PMID 23678184.
- PMID 22194844.
- PMID 20856677.
- PMID 24349255.
- S2CID 29450691.
- PMID 29027919.
- PMID 17431003.
- PMID 24850428.
Further reading
- Ramji DP, Foka P (August 2002). "CCAAT/enhancer-binding proteins: structure, function and regulation". The Biochemical Journal. 365 (Pt 3): 561–75. PMID 12006103.
- Oyadomari S, Mori M (April 2004). "Roles of CHOP/GADD153 in endoplasmic reticulum stress". Cell Death and Differentiation. 11 (4): 381–9. PMID 14685163.
- Aman P, Ron D, Mandahl N, Fioretos T, Heim S, Arheden K, et al. (November 1992). "Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11)". Genes, Chromosomes & Cancer. 5 (4): 278–85. S2CID 1998665.
- Park JS, Luethy JD, Wang MG, Fargnoli J, Fornace AJ, McBride OW, Holbrook NJ (July 1992). "Isolation, characterization and chromosomal localization of the human GADD153 gene". Gene. 116 (2): 259–67. PMID 1339368.
- Ron D, Habener JF (March 1992). "CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription". Genes & Development. 6 (3): 439–53. PMID 1547942.
- Eneroth M, Mandahl N, Heim S, Willén H, Rydholm A, Alberts KA, Mitelman F (August 1990). "Localization of the chromosomal breakpoints of the t(12;16) in liposarcoma to subbands 12q13.3 and 16p11.2". Cancer Genetics and Cytogenetics. 48 (1): 101–7. PMID 2372777.
- Rabbitts TH, Forster A, Larson R, Nathan P (June 1993). "Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma". Nature Genetics. 4 (2): 175–80. S2CID 5964293.
- Crozat A, Aman P, Mandahl N, Ron D (June 1993). "Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma". Nature. 363 (6430): 640–4. S2CID 4358184.
- Chen BP, Wolfgang CD, Hai T (March 1996). "Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10". Molecular and Cellular Biology. 16 (3): 1157–68. PMID 8622660.
- Wang XZ, Ron D (May 1996). "Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase". Science. 272 (5266): 1347–9. S2CID 20439571.
- Fawcett TW, Eastman HB, Martindale JL, Holbrook NJ (June 1996). "Physical and functional association between GADD153 and CCAAT/enhancer-binding protein beta during cellular stress". The Journal of Biological Chemistry. 271 (24): 14285–9. PMID 8662954.
- Ubeda M, Vallejo M, Habener JF (November 1999). "CHOP enhancement of gene transcription by interactions with Jun/Fos AP-1 complex proteins". Molecular and Cellular Biology. 19 (11): 7589–99. PMID 10523647.
- Cui K, Coutts M, Stahl J, Sytkowski AJ (March 2000). "Novel interaction between the transcription factor CHOP (GADD153) and the ribosomal protein FTE/S3a modulates erythropoiesis". The Journal of Biological Chemistry. 275 (11): 7591–6. PMID 10713066.
- Gotoh T, Oyadomari S, Mori K, Mori M (April 2002). "Nitric oxide-induced apoptosis in RAW 264.7 macrophages is mediated by endoplasmic reticulum stress pathway involving ATF6 and CHOP". The Journal of Biological Chemistry. 277 (14): 12343–50. PMID 11805088.
- Satoh T, Toyoda M, Hoshino H, Monden T, Yamada M, Shimizu H, et al. (March 2002). "Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells". Oncogene. 21 (14): 2171–80. PMID 11948400.
- Qiao D, Im E, Qi W, Martinez JD (June 2002). "Activator protein-1 and CCAAT/enhancer-binding protein mediated GADD153 expression is involved in deoxycholic acid-induced apoptosis". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1583 (1): 108–16. PMID 12069855.
- Talukder AH, Wang RA, Kumar R (June 2002). "Expression and transactivating functions of the bZIP transcription factor GADD153 in mammary epithelial cells". Oncogene. 21 (27): 4289–300. S2CID 20369894.
External links
- DDIT3+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
This article incorporates text from the United States National Library of Medicine, which is in the public domain.